Physician profile
Julie E Lawrence
NPI 1538764451
$779.42
in general payments reported to CMS, 2019-2025
17 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.54 · 2022: $208 · 2023: $189 · 2024: $114 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $105.30 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $99.74 | 2023-2025 | Belbuca, Xtampza |
| Abbvie INC. | $86.20 | 2023-2025 | |
| Almatica Pharma LLC | $79.94 | 2022-2023 | Gralise |
| Protega Pharmaceutials INC | $68.98 | 2022 | |
| Pfizer INC. | $67.79 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.51 | 2023-2025 | Relistor |
| Tersera Therapeutics LLC | $36.59 | 2024-2025 | Prialt |
| Acadia Pharmaceuticals INC | $33.06 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.64 | 2022 | |
| Amgen INC. | $29.99 | 2022 | |
| Valinor Pharma, LLC | $20.58 | 2025 | Movantik |
| Grt US Holding, INC. | $19.96 | 2022 | |
| Scilex Pharmaceuticals INC. | $19.24 | 2023 | Ztlido |
| Masimo Corporation | $15.36 | 2024 | Set and Rainbow Set |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $14.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.